Literature DB >> 31527744

The search for an effective HFpEF treatment continues.

Irene Fernández-Ruiz1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31527744     DOI: 10.1038/s41569-019-0277-z

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.

Authors:  John J V McMurray; Scott D Solomon; Silvio E Inzucchi; Lars Køber; Mikhail N Kosiborod; Felipe A Martinez; Piotr Ponikowski; Marc S Sabatine; Inder S Anand; Jan Bělohlávek; Michael Böhm; Chern-En Chiang; Vijay K Chopra; Rudolf A de Boer; Akshay S Desai; Mirta Diez; Jaroslaw Drozdz; Andrej Dukát; Junbo Ge; Jonathan G Howlett; Tzvetana Katova; Masafumi Kitakaze; Charlotta E A Ljungman; Béla Merkely; Jose C Nicolau; Eileen O'Meara; Mark C Petrie; Pham N Vinh; Morten Schou; Sergey Tereshchenko; Subodh Verma; Claes Held; David L DeMets; Kieran F Docherty; Pardeep S Jhund; Olof Bengtsson; Mikaela Sjöstrand; Anna-Maria Langkilde
Journal:  N Engl J Med       Date:  2019-09-19       Impact factor: 91.245

  1 in total
  1 in total

1.  Multilayer myocardial strain improves the diagnosis of heart failure with preserved ejection fraction.

Authors:  Radu Tanacli; Djawid Hashemi; Marthe Neye; Laura Astrid Motzkus; Moritz Blum; Elvis Tahirovic; Aleksandar Dordevic; Robin Kraft; Seyedeh Mahsa Zamani; Burkert Pieske; Hans-Dirk Düngen; Sebastian Kelle
Journal:  ESC Heart Fail       Date:  2020-06-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.